Streetbeat News

Analyst Ratings

BLK

BlackRock, Inc. (NYSE:BLK) is set to release its Q3 earnings on Oct. 11, with expected earnings of $10.38 per share and revenue of $5.01 billion. Analysts have recently adjusted their price targets for BlackRock, with several maintaining positive ratings. The company also completed the acquisition of Global Infrastructure Partners.

Portfolio Pulse from Avi Kapoor

October 11, 2024 | 7:24 am

ARKG

ARKK

MRNA

Cathie Wood's Ark Invest sold over $9M in Moderna stock, despite the company's post-COVID plans. The sale involved ARK Genomic Revolution ETF and ARK Innovation ETF. Moderna's stock is under scrutiny with mixed analyst sentiments and a revised financial plan.

Portfolio Pulse from Benzinga Neuro

October 11, 2024 | 2:14 am

AMD

AMD shares fell 4% after the 'Advancing AI 2024' event, where new high-performance computing solutions were launched. Despite the drop, analysts remain optimistic with a 12-month price target of $191.19.

Portfolio Pulse from Erica Kollmann

October 10, 2024 | 9:26 pm

AIZ

Six analysts have evaluated Assurant (NYSE:AIZ) over the past three months, with a mix of bullish and indifferent ratings. The average 12-month price target has increased by 3.55% to $214.17. Analysts have raised their price targets, reflecting positive sentiment towards Assurant's market performance.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:01 pm

CLMB

Climb Global Solutions (NASDAQ:CLMB) has received mixed analyst ratings over the past three months, with a current average 12-month price target of $84.5. The company has shown strong financial performance, including a 12.66% revenue growth rate and impressive profitability metrics.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:01 pm

BIIB

Biogen (NASDAQ:BIIB) has received mixed analyst ratings over the past three months, with a recent decline in the average 12-month price target. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Biogen's financials show strong profitability and effective cost management, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:01 pm

WPC

W.P. Carey (NYSE:WPC) has been analyzed by 8 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target is $61.88, with a high of $66.00 and a low of $56.00. Recent analyst actions include both raises and lowers in ratings and price targets. W.P. Carey faces revenue challenges but maintains strong net margins and effective debt management.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm

RGA

Reinsurance Group of America Inc (NYSE:RGA) has received varied analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 5.26% to $240. Analysts have adjusted their ratings and price targets, reflecting positive sentiment and expectations for RGA's future performance. The company has shown strong revenue growth and profitability, though it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm

BIRK

Birkenstock Holding (NYSE:BIRK) has been analyzed by 9 financial analysts, showing a range of sentiments from bullish to somewhat bullish. Analysts have set a 12-month average price target of $68.0, with a high of $77.00 and a low of $60.00. The company's recent financial performance includes a 19.35% revenue growth rate and a net margin of 13.22%, both above industry averages. However, its return on equity is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm

DNLI

SNY

Denali Therapeutics' stock is declining after-hours following the discontinuation of its Phase 2 study of oditrasertib, as announced by its partner Sanofi. The study failed to meet primary and secondary endpoints. Analysts have mixed ratings on Denali, with some maintaining buy ratings and others a market perform rating.

Portfolio Pulse from Adam Eckert

October 10, 2024 | 8:58 pm